Hamilton Thomas Edward 4
4 · Larimar Therapeutics, Inc. · Filed Sep 20, 2022
Insider Transaction Report
Form 4
Hamilton Thomas Edward
Director
Transactions
- Purchase
Common Stock
2022-09-16$3.15/sh+317,460$999,999→ 507,590 total
Holdings
- 159,433(indirect: FA Life Sciences, Inc.)
Common Stock
Footnotes (1)
- [F1]Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022.